Skip to content
Screener

Odyssey Therapeutics ODTX EBIT

EBIT at other companies

Thor Industries logo
Thor IndustriesTHO
$123.82M-14.2%
Ambarella logo
AmbarellaAMBA
-$19.42M+24.9%
PVH logo
PVHPVH
$124.3M+137%
Brookdale Senior Living logo
Brookdale Senior LivingBKD
$51.78M+75.1%
Academy Sports and Outdoors logo
Academy Sports and OutdoorsASO
$74.66M+7.8%
Helios Technologies logo
Helios TechnologiesHLIO
$29.9M+75.9%

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+31.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—
FCF margin-5,203.9%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—
Current ratio11.4×—

Where this comes from

Calculated from Odyssey Therapeutics’s reported figures.

−$55.5Moperating income−$52.8Mincome before tax+$20.0Kinterest expense=-$55.47M

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's EBIT?
Odyssey Therapeutics (ODTX) reported EBIT of -$55.47M in Q2 2026.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Ask your AI about Odyssey Therapeutics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude